Pharmaceutical News and Articles

Sleepy Nurses Vulnerable To Common Cold, Other Infectious Diseases

Sleep-deprived night shift nurses are at greater risk for the common cold and other infectious diseases, a new study says. Shift work and its impact on quality

Hormone Therapy For Menopause Linked To Alzheimer's Hallmark

Hormone replacement therapy during menopause appears to be linked to a toxic brain protein that s a hallmark of Alzheimer s disease. Women over 70 had a faster

Diet During Pregnancy Might Increase ADHD, Autism Risk

A mother s diet during pregnancy can influence her child s risk of ADHD and autism, a new study says. In particular, the unhealthy hallmarks of a typical Wester

Common Vaginal Infection Should Be Treated as an STI, Study Says

A common vaginal infection that affects nearly 1 in 3 women worldwide should be reclassified as a sexually transmitted infection (STI), a new study suggests. Ba

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune HPV in HPV16-Positive Head and Neck Cancer

PDS Biotechnology Corporation (Nasdaq PDSB) ( PDS Biotech or the Company ), a late-stage immunotherapy company focused on transforming how the immune system tar

Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis

Amgen (NASDAQ AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE 4151) today announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluat

Icotrokinra Results Show Potential to Set a New Standard of Treatment in Plaque Psoriasis

SPRING HOUSE, Pa. (March 8, 2025) Johnson Johnson (NYSE JNJ) today announced new icotrokinra (JNJ-2113) data from its comprehensive Phase 3 clinical program and

Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata

Q32 Bio Inc. (Nasdaq QTTB) ( Q32 Bio ), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

1 in 3 Kids Has Dental Problems, Poll Finds

More than 1 in 3 parents say their child has struggled with cavities, stained teeth, gum problems or tooth pain in the past two years, a new national poll shows